Fidelity Investments’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.62K Hold
8,289
﹤0.01% 4540
2025
Q1
$7.67K Hold
8,289
﹤0.01% 4580
2024
Q4
$7.13K Hold
8,289
﹤0.01% 4563
2024
Q3
$13.8K Hold
8,289
﹤0.01% 4323
2024
Q2
$13.3K Hold
8,289
﹤0.01% 4223
2024
Q1
$19K Hold
8,289
﹤0.01% 4035
2023
Q4
$18.7K Sell
8,289
-3
-0% -$7 ﹤0.01% 3980
2023
Q3
$25K Buy
8,292
+3
+0% +$9 ﹤0.01% 3694
2023
Q2
$34.2K Hold
8,289
﹤0.01% 3621
2023
Q1
$31.1K Hold
8,289
﹤0.01% 3646
2022
Q4
$46.3K Hold
8,289
﹤0.01% 3465
2022
Q3
$55K Sell
8,289
-746
-8% -$4.95K ﹤0.01% 3453
2022
Q2
$90K Sell
9,035
-7,134
-44% -$71.1K ﹤0.01% 3370
2022
Q1
$308K Sell
16,169
-273,589
-94% -$5.21M ﹤0.01% 3131
2021
Q4
$5.15M Buy
289,758
+10,807
+4% +$192K ﹤0.01% 2358
2021
Q3
$10.3M Buy
278,951
+994
+0.4% +$36.8K ﹤0.01% 2118
2021
Q2
$16.5M Sell
277,957
-165
-0.1% -$9.82K ﹤0.01% 1912
2021
Q1
$18.6M Sell
278,122
-4,207
-1% -$282K ﹤0.01% 1831
2020
Q4
$17.1M Sell
282,329
-3,874
-1% -$234K ﹤0.01% 1780
2020
Q3
$22.6M Sell
286,203
-12,115
-4% -$957K ﹤0.01% 1507
2020
Q2
$18.6M Sell
298,318
-35,002
-11% -$2.19M ﹤0.01% 1579
2020
Q1
$17.7M Sell
333,320
-20,230
-6% -$1.07M ﹤0.01% 1456
2019
Q4
$42.8M Sell
353,550
-18,869
-5% -$2.28M ﹤0.01% 1273
2019
Q3
$67.6M Sell
372,419
-25,582
-6% -$4.64M 0.01% 1040
2019
Q2
$51.7M Buy
398,001
+34,437
+9% +$4.48M 0.01% 1198
2019
Q1
$88.5M Buy
363,564
+1,797
+0.5% +$438K 0.01% 955
2018
Q4
$68.9M Buy
361,767
+120,767
+50% +$23M 0.01% 1013
2018
Q3
$79M Buy
241,000
+30,860
+15% +$10.1M 0.01% 1054
2018
Q2
$65.6M Sell
210,140
-176,275
-46% -$55M 0.01% 1150
2018
Q1
$94.1M Sell
386,415
-74,962
-16% -$18.3M 0.01% 1012
2017
Q4
$139M Sell
461,377
-122,660
-21% -$37M 0.02% 848
2017
Q3
$154M Buy
584,037
+56,408
+11% +$14.9M 0.02% 781
2017
Q2
$139M Sell
527,629
-59,176
-10% -$15.6M 0.02% 822
2017
Q1
$211M Sell
586,805
-2,936
-0.5% -$1.06M 0.03% 670
2016
Q4
$170M Buy
589,741
+264
+0% +$76.2K 0.02% 753
2016
Q3
$201M Buy
589,477
+686
+0.1% +$234K 0.03% 666
2016
Q2
$250M Buy
588,791
+640
+0.1% +$272K 0.03% 569
2016
Q1
$188M Buy
588,151
+54,627
+10% +$17.5M 0.03% 681
2015
Q4
$277M Buy
533,524
+80,206
+18% +$41.6M 0.04% 519
2015
Q3
$133M Buy
453,318
+47,872
+12% +$14M 0.02% 832
2015
Q2
$159M Sell
405,446
-35,062
-8% -$13.8M 0.02% 811
2015
Q1
$133M Buy
440,508
+47,707
+12% +$14.4M 0.02% 899
2014
Q4
$87.4M Buy
392,801
+11,156
+3% +$2.48M 0.01% 1067
2014
Q3
$88.5M Buy
381,645
+47,764
+14% +$11.1M 0.01% 1030
2014
Q2
$73.8M Buy
333,881
+38,463
+13% +$8.5M 0.01% 1168
2014
Q1
$93.2M Buy
295,418
+105,642
+56% +$33.3M 0.01% 1024
2013
Q4
$49.4M Sell
189,776
-11,610
-6% -$3.02M 0.01% 1326
2013
Q3
$29.5M Sell
201,386
-1,046
-0.5% -$153K ﹤0.01% 1538
2013
Q2
$30.7M Buy
+202,432
New +$30.7M 0.01% 1473